BNTX Stock Latest News

Goldman Sachs Picks 2 Stocks That Let Investors Buy the Dip or Ride the Momentum

PremiumStock Analysis & Ideas

1d ago

BioNTech Adds Chief People Officer to Management Board to Support Oncology Growth Strategy

SPOT

PremiumCompany Announcements

3d ago

BioNTech appoints Jimenez as Chief People Officer

PremiumThe Fly

3d ago

BioNTech’s New Phase III Prostate Cancer Trial Adds Long-Term Upside Potential for BNTX

PremiumCompany Announcements

5d ago

PremiumCompany AnnouncementsPfizer and BioNTech Move Closer to a Single-Shot Flu–COVID Vaccine: What Investors Should Watch

5d ago

PFE

Bristol-Myers Squibb and BioNTech Advance New Phase 3 Lung Cancer Trial With Pumitamig

Company Announcements

Bristol-Myers Squibb and BioNTech Advance New Phase 3 Lung Cancer Trial With Pumitamig

8d ago

Bristol-Myers Squibb and BioNTech Advance New Lung Cancer Weapon Against Keytruda in Phase 3 Trial

Company Announcements

Bristol-Myers Squibb and BioNTech Advance New Lung Cancer Weapon Against Keytruda in Phase 3 Trial

8d ago

Moderna Stock (MRNA) Hits a New 52-Week High — Can the Rally Last Through 2026?

PremiumMarket News

9d ago

GSK

MRK

PremiumCompany Announcements

BioNTech’s BNT142 Trial Termination: What It Means for the Oncology Pipeline and Investors

10d ago

The Stock Market Is Closed on MLK Day, but Here’s What Goldman Sachs Says to Buy When Trading Resumes

PremiumMarket News

13d ago

Midday Fly By: PNC reports Q4 beat, Regions reports quarterly miss

PremiumThe Fly

15d ago

CEG

PremiumThe FlySeagate upgraded, Tractor Supply downgraded: Wall Street’s top analyst calls

15d ago

BioNTech upgraded to Buy from Neutral at Goldman Sachs

The Fly

BioNTech upgraded to Buy from Neutral at Goldman Sachs

15d ago

BioNTech upgraded to Buy at Goldman Sachs on cancer potential

The Fly

BioNTech upgraded to Buy at Goldman Sachs on cancer potential

15d ago

BioNTech Outlines 2026 Strategy and Milestones at J.P. Morgan Healthcare Conference

PremiumCompany Announcements

17d ago

BioNTech: Stable COVID-19 Vaccine Base and Catalyst-Rich Oncology Pipeline Support Buy Rating

PremiumRatings

18d ago

BioNTech outlines 2026 areas of focus

PremiumThe Fly

19d ago

BioNTech Maps Out Catalyst-Rich 2026 Oncology Agenda at J.P. Morgan Healthcare Conference

PremiumCompany Announcements

19d ago

PremiumCompany AnnouncementsBioNTech and Bristol-Myers Squibb Push Deeper Into Pancreatic Cancer With New Phase II Trial

22d ago

BioNTech Completes CureVac Takeover and Updates Articles of Association

Company Announcements

BioNTech Completes CureVac Takeover and Updates Articles of Association

25d ago

Kennedy scales back number of vaccines recommended for children, NYT says